Alzheimer’s Study

Eli Lilly (Remternetug)

We are currently enrolling in a study for people with a gradual decrease in cognitive function for at least 6 months.

  • Patients must be 60-85 years of age.
  • To be eligible the patient will receive an amyloid PET scan that shows the presence of amyloid plaque in the brain.
  • All patients must have a reliable study partner.
  • 9 study visits total over 52 weeks.